Diagnostic Antibodies Against:
T-Cells, NK Cells, Receptors and Cytokines
Hybridoma
Binding Site
Isotype
Antigen
B33.1
IgG2a
HLA-DR antigens
(non-polymorphic determinants)
Anti-myelomonocytic cells
Hybridoma
Binding Site
Isotype
Antigen
B52.1
CD 14
IgM
monocytes (55,000 MW antigen)
B40.8
CD 15
IgM
granulocytes from precursors cells to mature polymorphs (145,000
MW glycoprotein and glycolipids) also reacting with colon-carcinoma
and other tumors and with mouse embryonic antigen (SSEA1)
similar to My1
B43.4
CD 11b
IgG2b
Granulocytes from promyelocytes to polymorphs, monocytes
and natural killer cells (similar to OK1, Mac1)
Anti-lymphocytes
Hybridoma
Binding Site
Isotype
Antigen
B67.1
CD 2
B67.6
CD 2
B66.6
CD 4
IgG1
Helper T cells (similar to OKT4, Leu 3, T4)
B36.1
CD 5
IgG2b
cells (67,000 MW glycoprotein)
B116.1
CD 8
IgG2a
Cytotoxic/suppressor T cells, NK cells (33K)
Anti-platelets
Hybridoma
Binding Site
Isotype
Antigen
B59.2
CD 61
IgG2a
Anti-glycoprotein IIIa on platelets
B1.12
CD 9
IgG1
21K antigens on platelets and some lymphocytes, coded for
by chromosome 12
Anti-human lymphokines
Hybridoma
Isotype
Antigen
B133.1
IgG1
Immune (gamma) interferon
B151.1
Tumor necrosis factor
B154.2
Tumor necrosis factor
B154.7
Tumor necrosis factor
C9.1
GM-CSF
C16.3
GM-CSF
Contact:
Meryle J. Melnicoff, Ph.D.
Director, Business Development The Wistar Institute
Phone: (215) 898-0049
melnicoff@wistar.org
